← All Sponsors
SPONSOR

DalCor Pharmaceuticals

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Acute Coronary Syndrome
NCT05918861 Phase 3
Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome
United States, Canada, Puerto Rico View Trial →